Adrian Senderowicz's Net Worth
$1.81 Million
Who is Adrian Senderowicz?
Adrian Senderowicz has an estimated net worth of $1.81 Million. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Ignyta, Inc., PUMA BIOTECHNOLOGY, INC., and Cerulean Pharma Inc..
SEC CIK
Adrian Senderowicz's CIK is 0001616230
Past Insider Trading and Trends
2015 was Adrian Senderowicz's most active year for acquiring shares with 6 total transactions. Adrian Senderowicz's most active month to acquire stocks was the month of May. 2019 was Adrian Senderowicz's most active year for disposing of shares, totalling 5 transactions. Adrian Senderowicz's most active month to dispose stocks was the month of October. 2019 saw Adrian Senderowicz paying a total of $150,048.32 for 139,655 shares, this is the most they've acquired in one year. In 2020 Adrian Senderowicz cashed out on 28,714 shares for a total of $568,366.41, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONSTELLATION PHARMACEUTICALS INC No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$27.85 | -$417,931.34 | 15.88K |
Scheduled
|
May 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
$16.82 | -$615,800.28 | 15.88K |
Scheduled
|
Nov 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
∞
| 15.88K |
$5.51 | $87,520.84 | 15.88K |
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ignyta, Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PUMA BIOTECHNOLOGY, INC. (PBYI) Snapshot price: $5.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$3.45 | -$93,279.60 | 27K |
Jun 13
| |||
Form 4
| -50.78% | -27.86K |
$2.63 | -$73,302.76 | 27K |
Scheduled
|
Jun 16
| ||
Form 4
| +96.92% | 27K |
—
|
—
| 54.86K |
Jun 14
| |||
Form 4
|
∞
| 27.86K |
—
|
—
| 27.86K |
Jun 15
| |||
Form 4
| -100.00% | -40.99K |
$11.17 | -$457,756.53 |
0
|
Jun 11
| |||
Form 4
| -19.61% | -10.00K |
$9.89 | -$98,878.00 | 40.99K |
Jun 11
| |||
Form 4
| +101.99% | 25.75K |
—
|
—
| 50.99K |
Jun 9
| |||
Form 4
| +333.61% | 19.42K |
—
|
—
| 25.25K |
Jun 10
| |||
Form 4
|
∞
| 5.82K |
—
|
—
| 5.82K |
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cerulean Pharma Inc. (DARE) Snapshot price: $0.3302
SVP, Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||